Topics

Slideshows

These drugs treat everything from cancer to cognitive decline.

The 7 new drugs expected to hit $1 billion in sales in five years

Articles

Apretude is approved for use in at-risk adults and adolescent to reduce the risk of sexually acquired HIV.

FDA approves HIV pre-exposure preventive injection

Blood clot risk in J&J higher for women, draws CDC concerns

CDC recommends Moderna and Pfizer in adults over Johnson & Johnson

Podcasts

Sanjay Rajagopalan, MD, the Herman K. Hellerstein, MD, chair in cardiovascular research at University Hospitals of Cleveland Harrington Heart & Vascular Institute, discusses the link between cardiovascular disease and air pollution and how primary care doctors can help patients lower their risk of cardiovascular disease caused by air pollution. 

How doctors can help patients lower risk of heart disease caused by air pollution

Identifying and assisting patients with social determinants is challenging, but can boost outcomes

What primary care physicians need to know about social determinants of health

Women and those in their 50s and early 60s reported the most stress about COVID

Poll identifies patients most at-risk during holidays

PreHevbrio is the only 3-antigen vaccine for Hepatitis B approved for adults

Hepatitis B vaccine for adults approved by FDA

Is more testing the answer to a worsening drug crisis?

Physicians fear harmful drug abuse went unnoticed during the COVID-19 pandemic

The "Cures 2.0" bill, if signed into law, would expand medical research, aid development of new therapies and expand telehealth. 

Cures 2.0 legislation introduced: Would fund disease research, telehealth expansion

The product is the first interchangeable insulin biosimilar approved by the FDA.

Chronic Conditions